Representative before the EPO

Employment test 51 - 200 employees
Company dna mewburn ellis llp
operating since 1890
Headquarter in London and 4 offices
active in Legal Services

Representative before the EPO

Employment test 501 - 1000 employees
Company dna olswang llp
operating since 1981
1002.41
Headquarter in London and 8 offices
active in Legal Services and IP Consulting

Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

We have observed 21 EP applications Hilary Mary van der Hoff has served for within the last five+ years. (We consider all applications which have an EP A1 publication dated after December 15, 2012). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP11797116

POCHOXIME CONJUGATES USEFUL FOR THE TREATMENT OF HSP90 RELATED PATHOLOGIES

IPC classification:
A61K 31/335, A61K 31/7048, A61P 35/00, C07D 313/00, C07D 495/04, C07H 15/26
Applicant:
Université de Strasbourg
Applicant:
Centre National de la Recherche Scientifique (CNRS)
Agent:
Multiple attorneys, Mewburn Ellis LLP
Status:
APPLICATION WITHDRAWN
EP11807376

SQUASH LEAF CURL VIRUS (SLCV) RESISTANCE IN CUCURBITS

IPC classification:
A01H 1/00, A01H 1/04, A01H 5/00
Agent:
Multiple attorneys, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP11781363

NITRO FATTY ACIDS - NEUROPROTECTION AND/OR INHIBITION OF COGNITIVE DECLINE

IPC classification:
A23L 1/30, A23L 1/302, A61K 9/48, A61K 31/122, A61K 31/201, A61K 31/202, A61K 31/355, A61K 31/519, A61K 31/557, A61K 31/714, A61K 36/16, A61K 36/258, A61K 45/06
Agent:
Multiple attorneys, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP12825651

PEG-INTERFERON LAMBDA 1 CONJUGATES

IPC classification:
C07K 11/00, C12P 21/04
Agent:
Multiple attorneys, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12833767

VEGF/DLL4 BINDING AGENTS AND USES THEREOF

IPC classification:
A61K 39/00, C07K 16/00, C12P 21/08
Applicant:
OncoMed Pharmaceuticals Inc
Agent:
Multiple attorneys, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP12735490

IMMUNOCYTOKINE COMBINATION THERAPY

IPC classification:
A61K 38/20, A61K 47/48, C07K 14/525, C07K 14/54, C07K 16/18
Agent:
Multiple attorneys, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP11725997

SELECTIVE INTEGRIN INHIBITORS

IPC classification:
A61K 47/48, A61P 29/00, A61P 35/00, A61P 37/00, A61P 43/00
Applicant:
Elan Pharmaceuticals Inc.
Agent:
Hilary Mary van der Hoff, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11875114

METHODS FOR TREATING HYPERURICEMIA IN PATIENTS WITH GOUT USING HALOFENATE OR HALOFENIC ACID AND A SECOND URATE-LOWERING AGENT

IPC classification:
A61K 31/19
Agent:
Multiple attorneys, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP12864819

TAXANE AND ABEO-TAXANE ANALOGS

IPC classification:
A01N 43/52, A61K 31/335, A61K 31/357, C07D 309/00
Agent:
Multiple attorneys, Mewburn Ellis LLP
Status:
APPLICATION WITHDRAWN
EP11875217

METHODS FOR TREATING GOUT FLARES

IPC classification:
A01N 37/00, A61K 31/20
Agent:
Multiple attorneys, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP11875027

METHODS FOR TREATING GOUT IN PATIENT SUBPOPULATIONS

IPC classification:
A01N 37/00, A61K 31/20
Agent:
Multiple attorneys, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP12850629

HUMAN NOTCH RECEPTOR MUTATIONS AND THEIR USE

IPC classification:
C07H 21/00, G01N 33/48
Applicant:
OncoMed Pharmaceuticals Inc
Agent:
Multiple attorneys, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP12804651

ACID-LABILE LIPOPHILIC PRODRUGS OF CANCER CHEMOTHERAPEUTIC AGENTS

IPC classification:
A61K 31/265, A61K 47/44, C07D 317/24
Agent:
Multiple attorneys, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP11807988

PHYTOPHTHORA RESISTANCE IN SWEET PEPPERS

IPC classification:
A01H 5/00, C12Q 1/68
Agent:
Multiple attorneys, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP14166833

Metal delivery agents and terapeutic uses of the same

IPC classification:
A61K 31/145, A61K 31/28, A61K 31/30, A61K 31/315, A61K 31/555, A61K 33/30, A61K 33/34, A61P 9/00, A61P 25/00, A61P 31/00, A61P 35/00
Applicant:
University of Melbourne
Agent:
Multiple attorneys, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP12868058

CANCER TREATMENT AND MONITORING METHODS USING OX40 AGONISTS

IPC classification:
A61K 39/00, C12Q 1/68
Agent:
Multiple attorneys, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP12814264

RSPO BINDING AGENTS AND USES THEREOF

IPC classification:
A61K 38/17, A61K 39/395, A61K 45/06, A61P 35/00, C07K 14/71, C07K 16/18, C07K 16/28, C07K 16/30, C07K 16/46, G01N 33/574
Applicant:
OncoMed Pharmaceuticals Inc
Agent:
Multiple attorneys, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP11822279

CHROMATOGRAPHY METHODS

IPC classification:
B01D 15/16, B01D 15/20, B01D 15/22, B01D 15/32, G01N 30/34, G01N 30/56, G01N 30/60
Agent:
Multiple attorneys, Mewburn Ellis LLP
Status:
APPLICATION WITHDRAWN
EP11838481

METHODS FOR DETERMINING DIFFERENCES IN ALPHA-4 INTEGRIN ACTIVITY BY CORRELATING DIFFERENCES IN sVCAM AND/OR sMAdCAM LEVELS

IPC classification:
A61K 39/395, G01N 33/566, G01N 33/68
Applicant:
Elan Pharmaceuticals Inc.
Applicant:
Biogen Idec MA Inc.
Applicant:
Biogen MA Inc.
Agent:
Multiple attorneys, Mewburn Ellis LLP
Status:
The patent has been granted
EP11740315

POLYSACCHARIDE BASED ANTIMICROBIAL FORMULATIONS

IPC classification:
A01N 41/06, A61K 31/145, A61K 47/36
Agent:
Multiple attorneys, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14731098

BIOMARKERS FOR AGE-RELATED MACULAR DEGENERATION (AMD)

IPC classification:
G01N 33/68
Agent:
Multiple attorneys, Olswang LLP
Agent:
Robert John Stephen, CMS Cameron McKenna Nabarro Olswang LLP
Status:
EXAMINATION IN PROGRESS

Please Sign in to use this feature